Global Biodefense Market: Overview
Biodefense has been advancing,
particularly in the U.S., subsequent to the 2001 anthrax attack. The use
of biological warfare can be traced back to 1346 A.D. when plaque
afflicted human corpses were hurled over the besieged walls of Caffa.
Presently, the use of biological warfare is banned following a United
Nations convention signed in 1972. However, the absence of verification
protocol has not been sufficient to prevent countries from developing
biological warfare. Biological warfare has also become the weapons of
choice for terrorist organizations. To combat this, the development of
biodefense is an active research field.
Report Overview @ https://www.transparencymarketresearch.com/biodefense-market.html
The research report analyzes the global
biodefense market on the basis of market forces, current market trends,
and major geographies. The report is an in-depth analysis of industry
growth drivers, challenges, and opportunities of the market for the
forecast period. It includes an analysis of recent technological
developments in the market.
Using standard analytical tools such as
SWOT analysis, the report presents the strengths, weakness,
opportunities, and threats of the market until the end of the forecast
period in 2023. The report also covers an analysis impact of macro and
micro factors on the growth of the market, which is essential for
existing market players as well as new entities that are interested in
participating in the market. Thus, the report analysis helps in
formulating informed business decisions by receiving detailed insights
into the development of the key market segments.
Global Biodefense Market: Drivers and Restraints
The global biodefense market is
displaying admirable growth due to the increasing importance for disease
surveillance mission to combat bioterrorism. The outbreak of anthrax
subsequent to September 11, 2001, attack has raised vigilance among
government bodies for improving public health preparedness and to
improve the response time in the event of a disaster. The funding for
preparedness of bioterrorism has augmented the capabilities of Public
Health Services to enhance its surveillance activities, resulting in
effective monitoring of community health. The increasing focus of Public
Health Services for the development of tests and procedures to identify
biothreat agents is also driving the biodefense market. The recent
Ebola outbreak and nuclear crisis in Japan are anticipated to have a
positive impact on the growth of the biodefense market.
Global Biodefense Market: Regional Outlook
The global biodefense market is divided
into the regional segments of North America, Europe, Asia Pacific, and
the Middle East and Latin America. North America is the largest market
for biodefense due to enhanced lab capabilities and improved
infrastructure for raising alarm for the threat to health. Europe is the
second largest market for biodefense. Asia Pacific is expected to
emerge as a significant market for biodefense due to the increasing
adoption of precise analytical instruments and rapid advancement of the
biotechnology industry. Other regions such as the Middle East and Latin
America are anticipated to be significant regions for biodefense due to
the expanding portfolio of leading biotechnology players in these
regions.
Major Companies Mentioned in Report
Some of the leading companies operating
in the global biodefense market are Alnylam Pharmaceuticals, Dynavax
Technologies Inc., Emergent BioSolutions, SIGA Technologies, Acambis
plc, Evogen Inc., Human Genome Sciences, and PharmAthene Inc.
No comments:
Post a Comment